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Bovine conglutinin is an immune protein that is involved in
host resistance to microbes and parasites and interacts with
complement component iC3b, agglutinates erythrocytes, and
neutralizes influenza A virus. Here, we determined the high-
resolution (0.97–1.46 Å) crystal structures with and without
bound ligand of a recombinant fragment of conglutinin’s C-ter-
minal carbohydrate-recognition domain (CRD). The structures
disclosed that the high-affinity ligand N-acetyl-D-glucosamine
(GlcNAc) binds in the collectin CRD calcium site by interacting
with the O3 and O4 hydroxyls alongside additional specific
interactions of the N-acetyl group oxygen and nitrogen with
Lys-343 and Asp-320, respectively. These residues, unique to
conglutinin and differing both in sequence and in location from
those in other collectins, result in specific, high-affinity binding
for GlcNAc. The binding pocket flanking residue Val-339,
unlike the equivalentArg-343 in thehomologous human surfac-
tant protein D, is sufficiently small to allow conglutinin Lys-343
access to the bound ligand, whereas Asp-320 lies in an extended
loop proximal to the ligand-binding site and bounded at both
ends by conserved residues that coordinate to both calcium and
ligand. This loop becomes ordered on ligand binding. The elec-
tron density revealed both  and  anomers of GlcNAc, consis-
tent with the added /GlcNAc mixture. Crystals soaked with
1–2 mannobiose, a putative component of iC3b, reported to
bind to conglutinin, failed to reveal bound ligand, suggesting a
requirement for presentation of mannobiose as part of an
extended physiological ligand. These results reveal a highly spe-
cific GlcNAc-binding pocket in conglutinin and a novel collec-
tin mode of carbohydrate recognition.
The collectin family of mammalian innate immune system
proteins recognizes pathogens by the repeating pattern of car-
bohydrates on their surfaces and organizes their disposal
through neutralization, agglutination, and opsonization while
recruiting immune system cells for their destruction (1, 2). Col-
lectins are also involved in clearance of apoptotic cells and
modulation of inflammatory and immune responses (3, 4). The
surfactant proteins SP-A and SP-D are found in the lung where
they form the first line of defense against inhaled pathogens and
allergens. Mannose-binding lectin (MBL)5 is a serum protein
which, in common with CL-L1, CL-K1, and CL-P1, is able to
activate the complement system to dispose of pathogens (5, 6).
In addition to the collectins found in othermammals, the family
Bovidae has three serum collectins: bovine conglutinin, CL-43,
and CL-46. Phylogenetic analysis indicates that these bovine
collectins evolved from a common ancestral SP-D gene after
the divergence of the Bovidae from the mammalian line (7).
The rapid evolution of additional collectins suggests that
their presence confers a survival advantage to the animals. The
digestive system in ruminants relies on a symbiotic relationship
with vast numbers of microorganisms in the rumen, which are
able to break down the cellulose in food. The bovine serum
collectins provide extra defense against microorganisms which
leak into the bloodstream. As well as binding, neutralizing, and
opsonizing the microorganisms, it is thought that they lead to
reduction in inflammatory responses (7), whereas low conglu-
tinin levels in plasma are associated with increased susceptibil-
ity to infection (8). Mice injected with conglutinin followed by
Salmonella typhimurium showed significantly reduced blood
bacterial levels and greater survival compared with controls
(9). In vitro experiments also demonstrated antibacterial
activity of conglutinin against S. typhimurium and Esche-
richia coli (9). In addition to this antimicrobial role, conglu-
tinin levels in the Bovidae vary with diet, season, infections,
and stage of the reproductive cycle (10), with a significant
presence in fetal serum (11). The significance of these vari-
ations remains unclear.
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Bovine serum conglutinin has been shown to bind, through
the globular carbohydrate recognition domain (CRD), to spe-
cific carbohydrate structures on complement effector protein
iC3b, which arises following activation and cleavage of comple-
ment component C3 (12). This is thought to enhance com-
plement-dependent clearance through agglutination of com-
plement-reacted microorganisms. The iC3b -oligosaccharide
is of high-mannose type, being (Man)9(GlcNAc)2-Asn or
(Man)8(GlcNAc)2-Asn (13, 14), and the binding is proposed to
be via the terminal 1–2 mannobiosyl unit (15). It is suggested
that C3b undergoes a conformational change that exposes its
glycan when cleaved (iC3b) leading to conglutinin recognition
of iC3b (13). The binding of conglutinin to iC3b is inhibited
by N-acetylglucosamine (GlcNAc) (12) which, unique to the
bovine collectins conglutinin and CL-46, is reported to be the
highest affinity ligand, in the case of conglutinin by an order of
magnitude relative to other monosaccharide ligands such as
N-acetyl mannosamine (ManNAc), mannose and glucose and
to the maltose disaccharide (16–20). Conglutinin has been
shown to bind to some complex-type as well as high mannose-
type oligosaccharide chains (21). This is thought to be via ter-
minal GlcNAc ormannose residues, and for the highmannose-
type there seems to be a preference for the terminal man1–2
sequence although there is increased reactivity from the Man5
to the Man8 structures. Complement-independent anti-myco-
bacterial activity has also been demonstrated for a recombinant
neck plus CRD fragment of conglutinin which is thought to
bind directly to Mycobacterium bovis Bacille Calmett-Guérin
(BCG) lipoarabinomannan in a calcium-dependent manner,
inhibiting uptake by macrophages (22). Binding to yeast carbo-
hydrate structures including zymosan and mannan has also
been reported (23).
Bovine serum conglutinin has been shown to inhibit influ-
enza A virus (IAV) more efficiently than other collectins, and a
functionally intact recombinant homotrimer (neck plus CRDs)
(24) has been shown to be active against IAV (25). An engi-
neered SP-D/conglutinin (neck/CRD) fusion protein (26)
appears to combine the beneficial properties of the two com-
ponents with enhanced IAV neutralizing activity, whereas tar-
geted mutation (SP-D R343V) enhances SP-D recognition of
highmannose viral glycans (27). Reported ligand-bound crystal
structures include CRD and trimeric fragments of MBP/MBL,
and trimeric fragments of humanSP-D, porcine SP-D, rat SP-A,
and CL-K1 (27–37). These structures reveal a conserved calci-
um-binding site within the CRD as part of the significant
sequence conservation throughout the ligand-binding domain
of the CRD.
We present here high-resolution crystal structures with and
without bound ligand of a recombinant fragment of the C-ter-
minal carbohydrate recognition domain of conglutinin, the first
crystal structures of a bovine collectin. The results reveal a
highly specific binding pocket for GlcNAc, as opposed to other
monosaccharide ligands, and a novel collectin mode of carbo-
hydrate recognition which utilizes interactions which extend
beyond the conserved collectin calcium-binding pocket and the
binding-site flanking residues.
Results
Protein expression and purification
Expression of the trimeric recombinant neck plus CRD con-
glutinin fragment provided 40 mg protein per liter culture,
with almost all the protein in the inclusion bodies as evidenced
by the absence of corresponding protein in the sonicate super-
natant. The recombinant fragment showed a relativemolecular
mass of 23 kDa under reducing conditions on a 15% (w/v)
acrylamide gel, corresponding to the monomeric recombinant
neck plus CRD (rfBC) (Fig. 1a). The recombinant fragment
sequence is shown in Fig. 2.
The protein eluted as a single peak from a Q-Sepharose col-
umn and the subsequent Mono Q column at salt concentra-
tions of 200 mM and 225 mM, respectively. Following ion
exchange purification, the MW of rfBC under nondissociating
conditions was determined by gel filtration, the recombinant
protein eluting as a single peak corresponding to 64KDa, which
indicated the trimeric nature of the recombinant rfBC (Fig. 1b).
TheN-terminal sequence obtained following chromatographic
purification and characterization was GSAEANALKQRVTIL-
DGHLRRFQNAFSQYKKAVLFPDGQA, where the first five
residues GSAEA are from the vector. Only a single sequence
was observed, with the conglutinin sequence starting at Asn-
199 in agreement with the published sequence in the protein
Figure 1. Expression and purification of rfBC. a, reducing 15% SDS-PAGE
analysis of the expression of rfBC. Lane 1, lowmolecular weightmarkers; lane
2, total cell lysate of uninduced cells; lane 3, total cell lysate of induced cells
harvested2hpost induction and chilled for 30minon icewith shaking; lane 4,
sonicated supernatant; lane 5, refoldedprotein after overnight dialysis; lane 6,
dialysate pellet containing insoluble material. b, gel-filtration chromatogra-
phy elution profile of rfBC. Following ion exchange purification of the
expressed rfBC protein (Q-Sepharose followed by Mono Q) the purified pro-
tein was run at a flow rate of 1 ml/min (tris/EDTA buffer) through a Super-
dex75 gel-filtration column. 0.5 ml volume fractions were collected. The
molecular mass standards alcohol dehydrogenase (150 kDa), BSA (66 kDa),
carbonic anhydrase (29 kDa), and cytochrome C (14.4 kDa) used for calibra-
tion are shown.
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database (Fig. 2). Cysteine residues are present only in the CRD
of the recombinant fragment (Fig. 2).
Crystallization of the purified protein resulted in unliganded
and ligand-bound crystal structures of the recombinant frag-
ment of bovine conglutinin which revealed a monomeric CRD
rather than the expressed trimeric rfBC. The protein used for
crystallization, several months after the initial preparation, was
recharacterized by N-terminal sequencing and SDS-PAGE
(data not shown). The results showed that 80% of the prepara-
tion had the N-terminal sequence starting at conglutinin Lys-
224 or Ala-225 whereas the remaining 20% was composed
almost equally of material starting at conglutinin Arg-214 and
Val-205 (Fig. 2). The SDS gel of the protein also showed that the
molecular weight of the majority of the recombinant fragment
was less than that expected for the recombinant neck plus CRD
monomer. This indicates that the majority of the protein used
in the crystallization had lost a substantial amount of the neck
region between initial preparation and crystallization andwas a
monomer of 21.3 kDa, which is consistent with the monomeric
CRD fragment seen in the crystal structures.
Crystal structure
Both unliganded and ligand-soaked structures have been
determined. The initial structure of the conglutinin CRD
showed electron density at the CRD ligand-binding site (Ca1)
into which the cryoprotectant, ethylene glycol, was subse-
quently fitted. A further structure was therefore determined, to
a higher resolution of 0.97 Å, utilizing 2,4 methanepentanediol
(MPD) as an alternative cryoprotectant. This structure did not
show any extra electron density in the ligand-binding site,
except for water molecules, and is therefore designated as the
native structure. To investigate the structural detail of the
known binding properties and specificities of conglutinin (16–
20), various ligands which should be able to access the binding
site in the crystal were introduced into crystals by adding ligand
to cryobuffers. These included GlcNAc, maltoheptaose, inosi-
tol 1-monophosphate, -1,2-mannobiose, and ManNAc. Only
the highest affinity ligand,GlcNAc,was visualized in the ligand-
binding site along with the closely similar N-acetyl--D-gluco-
samine 1-phosphate (GlcNAc-1-P) (Fig. 3). Initial experi-
ments for -1,2-mannobiose, implicated in the binding of
conglutinin to iC3b, used a ligand molar excess of three times
that was successfully used for GlcNAc but did not show any
ligand in the crystal. Extending the soaking time and final ligand
concentration in the cryobuffers still did not show the ligand in
the binding site, or at any other location in the protein. The
GlcNAc and GlcNAc-1-P ligand-bound structures were sub-
sequently refined along with the unliganded and ethylene
glycol–bound structures (see Table 1).
The conglutinin CRDmonomer has an overall topology sim-
ilar to that of the known collectin structures (Fig. 4). In all struc-
tures, calcium Ca1 is present at the collectin CRD ligand-bind-
ing site. Additionally, except for the structure without bound
ligand, there is evidence of a calcium ion in the collectinCa2 site
although the electron density and the average B-factors (Ca1
14.0 Å2, Ca2 33.0 Å2) suggest this site is not as fully occupied as
Ca1, particularly for the ethylene glycol and GlcNAc-1-P
structures. In the unliganded structure, the lack of electron
density for the calcium ion at the Ca2 site is accompanied by
a lack of electron density, or movement away from the site,
for some of the side chains of the Ca2 coordinators. There is
no electron density in any of the structures to support the
presence of the third calcium ion observed in some collec-
tins. Ca1 is coordinated in a similar way to other structurally
characterized collectins (Fig. 5 and Table 2). Protein coordi-
nation to Ca1 is by Glu-315, Asn-317, Glu-325, Asn-337,
Asp-338, and the carbonyl O of Asp-338. In the ligand-
bound structures Ca2 is coordinated by Asp-291 (2), Glu-
295 (2), Asn-318 (this interaction is not present in the
GlcNAc-1-P–bound structure), Asn-326, the carbonyl O
of Glu-325, and one water molecule.
Ligand-binding site
Adjacent to the calciumCRD site, the longer of the two loops
involved in binding to the calcium ions (see Fig. 4) has an inser-
tion compared with the homologous collectin human surfac-
tant protein D (hSP-D) (Fig. 6). These additional two residues
compared with hSP-D result in an extended loop near the CRD
ligand–binding site, in a similar manner to pig surfactant pro-
tein D (pSP-D). In the unliganded and GlcNAc-1-P–bound
structures this Asn-318–Pro-324 loop is disordered (318–
323). Upon binding of the ligand GlcNAc or ethylene glycol the
318–324 loop becomes ordered, although the electron density
is not as clearly defined as in themajority of the CRD structure.
Within the structure without bound ligand there is some ill-
Figure2.Sequenceof the rfBCrecombinant fragment.The first five aminoacidsGSAEA (GLAEV in conglutinin) are vectorderived. The truncatedmonomeric
fragment used for structure determination is underlined with the sites of proteolysis within the  helical coiled coil neck region, leading to the truncated
fragment, indicated by the vertical arrows.
Figure 3. Electron density for the GlcNAc-1-P ligand bound to con-
glutinin. Conglutinin ligand-binding site with GlcNAc-1-P ligand shown
as ball-and-stickmodel. The 1.0 Å resolution electron density map (blue) is
2mFo DFc contoured at 1. The calcium ion is in green with calcium and
ligand coordinating residues Glu-315, Asn-317, Glu-325, and Asn-337 are
shown as stick models.
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defined electron density for the loop that could correspond to
the ligand-bound loop, suggesting a small degree of order.
However, it would not have been possible to discern the loca-
tion of the loop without the prior knowledge of the position of
the loop in the ligand-bound structures, supporting that the
loop is mobile in the absence of ligand.
The GlcNAc-bound structure shows evidence of both  and
 anomers present in the electron density (Fig. 5), reflecting the
heterogeneous mixture of the commercially sourced GlcNAc.
GlcNAc interacts with the CRD calcium and its coordinators
Glu-315 OE2, Asn-317 ND2, Glu-325 OE2, and Asn-337 ND2
via theO3 andO4 hydroxyls, withAsp-320 from the extended
loop interacting with the N group of GlcNAc ( 3.04 Å;  3.18
Å) (Table 2). Additionally, Lys-343NZ interacts withO7 on the
acetyl head group (2.79–2.83 Å) (Fig. 5). Lys-343 adopts the
same conformation in all the structures, being held in place by
Glu-329, which in turn is interacting with Asn-337 which coor-
dinates Ca1 and hydroxyl of bound ligand (Fig. 7). There is
some evidence in the electron density of an interaction between
Table 1
Crystallographic data and refinement statistics for conglutinin
Figures in parentheses refer to the highest resolution bin. r.m.s.d., root mean square deviation.
Native conglutinin
Ethylene glycol–bound
conglutinin
GlcNAc-bound
conglutinin
GlcNAc-1-P–bound
conglutinin
Data collection
Synchrotron station DLS I03 SRS 14.2 SRS 14.1 DLS I04
Wavelength (Å) 0.920 0.985 1.488 0.827
Temperature (K) 100 100 100 100
Space group P43 P43 P43 P43
Cell dimensions (Å) a 50.17 c 52.25 a 50.82 c 52.84 a 50.22 c 51.93 a 50.28 c 52.19
Resolution range (Å) 50.0–0.97 (1.02–0.97) 52.9–1.25 (1.29–1.25) 25.1–1.46 (1.54–1.46) 50.3–1.0 (1.004–1.0)
Observations 471,902 (4289) 348,475 (10,133) 116,659 (1258) 538,352 (7243)
Unique reflections 61,261 (1888) 35,164 (2367) 18,301 (714) 70,046 (985)
Completeness (%) 81.2 (20.5) 94.3 (66.9) 80.8 (21.8) 99.7 (99.9)
Rmergea 0.050 (0.216) 0.034 (0.199) 0.036 (0.121) 0.040 (0.389)
I/(I) 7.0 (3.2) 12.3 (3.5) 9.9 (2.8) 9.5 (2.0)
Refinement
Protein atoms 902 946 943 911
Residues chain A 230–317, 324–351 230–351 230–351 230–317, 323–351
Other atoms
Calcium ions 1 2 2 2
Ligand 4 15 (2) 19
Water 141 101 149 173
Rworkb (%) 0.135 0.181 0.161 0.124
Rfreec (%) 0.139 0.203 0.184 0.140
r.m.s.d. bond length (Å) 0.01 0.01 0.010 0.011
r.m.s.d. bond angle (°) 1.65 1.68 1.38 1.78
Average B-values (Å2)
Protein 14.60 16.23 14.05 12.99
Water 25.54 24.14 25.05 26.67
Other hetero-atoms 16.95 21.67 15.83 17.01
Ramachandran plot values (%)d
Favored 99.1 96.7 97.5 99.1
Outliers 0.0 0.0 0.0 0.0
PDB ID 6RYG 6RYJ 6RYM 6RYN
a Rmerge hj Ih,j Ih/hj Ih,j, where Ih,j is the jth observation of reflection h and Ih is the mean of the jmeasurements of reflection h.
b Rconv h Foh Fch/h Foh, where Foh and Fch are the observed and calculated structure factor amplitudes, respectively, for the reflection h.
c Rfree is equivalent to Rconv for a 5% subset of reflections not used in the refinement.
d Defined according to MolProbity.
Figure 4. Structure of the CRD. Overlay of conglutinin (gray), hSP-D (blue),
and pSP-D (orange) CRDs generated by superposing (least squares fit ofmain
chain) conglutinin residues 232–319 and325–351with equivalent residues in
PDB ID 1PWB and PDB ID 4DN8. a, overlay illustrating the location of the
calcium ions, Ca1, Ca2, and Ca3, with Ca3 only found in hSP-D. The long loop
indicated corresponds to residues 318–324 in conglutinin. b, GlcNAc-bound
conglutinin structure with ligand coordinating residues Asp-320, from the
long loop, and Lys-343 shown as sticks. For clarity only GlcNAc and conglu-
tinin Ca1 are shown.
Figure 5. GlcNAc binding in conglutinin CRD ligand site showing key
amino acids and interactions between bound ligand and protein.
Both GlcNAc and GlcNAc are seen in the binding site with the anomeric
carbon C1 indicated. Amino acid interactions are shown for GlcNAc.
GlcNAc interactions are the same except for that with Glu-321 which is
only present for GlcNAc. The Lys-246 interacting residue from a neigh-
boring subunit via a crystal contact is shown in blue and calcium ion Ca1 is
shown as a green sphere.
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Glu-321 in the extended loop and O1 of the  anomer of
GlcNAc. In addition to the CRD interactions with theN-acetyl
group, Lys-246 from a symmetry-related molecule interacts
with GlcNAc O5 and O6 (Fig. 5). This residue is in a similar
orientation in all the structures determined, including that
without ligand, regardless of interactions between protein and
ligand. TheGlcNAc-1-P–bound structure shows ligand bind-
ing in the calcium site and the additional protein-ligand inter-
action with Lys-343 as seen for GlcNAc. Residues 318–323 in
the extended loop are disordered in the GlcNAc-1-P struc-
ture, the bulky -linked phosphate precluding the interaction
of Asp-320 with the ligand nitrogen (Fig. 3) and preventing the
loop adopting the orientation seen in the other ligand-bound
structures.
The structure of the conglutinin CRD with ethylene glycol
from the cryoprotectant bound at the ligand-binding site
reveals ligand binding in a similar manner to that seen for all
collectin ligands to date. Two hydroxyls from ethylene glycol,
which have the same configuration as the O3 and O4 man-
nose-type pair, interact with the binding-pocket residues and
Ca1. For this small ligand no further interactions with protein
are seen. Although the 318–324 loop in the ethylene glycol–
Table 2
Calcium- and ligand-binding distances (Å)
Lys-246 refers to a residue from a symmetry related molecule in the crystal. W corresponds to water molecule. Dash means no interaction.
Atom 1 Atom 2
Native
conglutinin
Ethylene
glycol ligand
GlcNAc
ligand
GlcNAc
ligand
GlcNAc-1-P
ligand
Ca1 Glu-315 OE1 2.49 2.62 2.62 2.62 2.56
Asn-317 OD1 2.44 2.48 2.44 2.44 2.43
Glu-325 OE1 2.43 2.53 2.39 2.39 2.44
Asn-337 OD1 2.42 2.51 2.43 2.43 2.41
Asp-338 OD1 2.27 2.34 2.30 2.30 2.32
Asp-338 O 2.56 2.61 2.48 2.48 2.51
Ligand
OA — O1: 2.57 O3: 2.76 O3: 2.41 O3: 2.58
OB — O2: 2.52 O4: 2.52 O4: 2.37 O4: 2.50
W
2.46 — — — —
3.50 — — — —
Ligand
OA Glu-325 OE2 — O1: 2.60 O3: 2.42 O3: 2.54 O3: 2.60
Asn-337 ND2 — O1: 3.05 O3: 2.92 O3: 2.84 O3: 2.92
OB Glu-315 OE2 — O2: 2.69 O4: 2.70 O4: 2.59 O4: 2.62
Asn-317 ND2 — O2: 3.00 O4: 3.07 O4: 2.90 O4: 3.29
O7 Lys-343 NZ — — 2.79 2.83 2.87
N Asp-320 OD1 — — 3.04 3.18 —
O1 Glu-321 OE1 — — 2.88 4.87 —
O5 Lys-246 NZ — — 2.97 3.09 3.15
O5 W — — 3.14 3.11 3.04
O6 Lys-246 NZ — — 2.89 2.72 2.92
O6 W — — 2.51 3.03 3.05 & 2.75
OP1 Lys-246 NZ — — — — 2.85
Ca2 Asp-291 OD1 — 2.86 2.66 2.66 2.81
Asp-291 OD2 — 2.33 2.33 2.33 2.26
Glu-295 OE1 — 3.12 2.57 2.57 2.82
Glu-295 OE2 — 2.72 2.56 2.56 2.81
Asn-318 OD1 — 3.14 2.65 2.65 —
Glu-325 O — 2.83 2.64 2.64 2.91
Asn-326 OD1 — 3.04 2.79 2.79 3.15
W — 2.30 2.33 2.33 2.09
Glu-329
OE1 Lys-343 NZ 2.77 2.83 2.79 2.79 2.76
OE2 Asn-337 ND2 2.82 2.91 2.85 2.85 2.80
Figure 6. Sequence alignment in the calcium- and ligand-binding region in the collectin CRD. Conserved residues are shaded gray and conserved Ca1
coordinators are yellow. The specific GlcNAc conglutinin N-acetyl interacting residues Asp-320 and Lys-343 along with the binding site flanking residues of
hSP-D, Asp-325, and Arg-343 (see Shrive et al., 32) are highlighted in cyan.
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bound structure makes no direct interactions with the ligand,
the loop is ordered and adopts the sameoverall conformation as
that seen in the GlcNAc-bound structure.
Discussion
The trimeric recombinant fragment comprises amino acids
199–351 of conglutinin, the N-terminal sequence of the prep-
aration being confirmed by sequencing. The crystal structure
however reveals only the monomeric CRD, with electron den-
sity definition at the N terminus starting at around amino acid
230 (the residue neighboring proline 229 at the neck-CRD
interface, Figs. 2 and 3). Subsequent N-terminal sequencing of
the protein used for crystallization revealed that the majority
(80%) starts at amino acid 224/225 (KAVLFP/AVLFP; Fig. 2)
consistent with the crystal structure. The remaining 20% gave
an N-terminal residue of either Arg-214 or Val-205 (Fig. 2). A
significant portion of the recombinant chain (25/26 residues for
the major component) is believed to have been proteolytically
cleaved just prior to the neck-CRD interface because of traces of
proteases in the preparation. The time delay of several months
between preparation and use, for crystallization, may also be a
contributory factor. The absence of the trimerizing neck resi-
dues, known to be essential for trimer formation (24, 38) results
in the dissociation of the three chains of rfBC to give themono-
meric CRD observed here.
The conglutinin CRD fold is very similar to the other known
collectin structures (Fig. 4). The overall structure is stabilized
by the two typical collectin CRD intermolecular disulfide
bridges, Cys-255–Cys-349 and Cys-327–Cys-341 here (Fig. 2).
No other cysteines are present in the expressed fragment pro-
viding no opportunity for intrachain disulfides to be formed
either in the full expressed trimeric fragment (Fig. 1b) or the
cleaved fragment present during crystallization.CalciumCa1 at
the CRD ligand site is coordinated by conserved collectin resi-
dues. The second calcium ionCa2 is not as tightly bound as Ca1
(as evidenced by higher B-factor comparedwith Ca1) and is not
observed in the structure without bound ligand. This may be
because of a number of interdependent factors including the
loss of order of 318–323 in the calciumbinding loop, loss ofCa2
coordination by Asn-318, the lack of an interaction between
Asp-320 and ligand, and low calcium concentration in the crys-
tallization buffer. A third calcium ion is not present in any of the
conglutinin CRD data consistent with the presence of Asn at
the Ca2/Ca3 coordinating residue conglutinin 326 rather than
the Asp present in rat MBP-A, hSP-D, and human MBL which
all contain a third calcium ion (Fig. 6).
Although the structures of the conglutininCRD reveal ligand
binding to calcium in a similar manner to that seen for all col-
lectin ligands to date, with two hydroxyls which have the same
configuration as the O3 and O4 hydroxyls of mannose/glu-
cose-type rings interacting with Ca1, there are additional spe-
cific interactions with the high-affinity GlcNAc ligand. The
N-acetyl head group interacts with Lys-343 (via O7) and with
Asp-320 (via N) in the extended conglutinin loop. Conglutinin
does not discriminate between the / GlcNAc anomers, with
the crystal structure suggesting that both are bound with simi-
lar occupancy despite an indication of an additional protein-
ligand interaction involving Asp-321 and the anomeric
hydroxyl O1 in the  anomer. As this anomer is only partially
occupied (as evidenced by the presence of both and forms in
the structure), this may explain why the Glu-321 density is not
as clearly defined asmay be expected for an interacting residue.
The head group NZ of conglutinin Lys-343 which interacts
with GlcNAcO7 is held in position by Glu-329 which is linked
to the collectin-conservedAsn-337which coordinates theCRD
calcium Ca1 and hydroxyl of bound ligand (Figs. 6 and 7). The
Lys-343 occupies a position between the small, hydrophobic
residues Val-339 and Leu-345 (Fig. 7) which are replaced in
hSP-D by Arg-349 (hSP-D numbering) and the key flanking
residue Arg-343. Thus in conglutinin the flanking residue Val-
339, equivalent to SP-D Arg-343, indirectly influences, and
enhances, GlcNAc binding by allowing O7 of the acetyl head
group direct access to Lys-343 NZ (NZ-O7 2.79–2.87 Å) (Fig.
7). Positioning GlcNAc in hSP-D in a similar manner to that
observed here would give a clash between the hSP-D Arg-343
head-group and ligand, specifically the acetyl head group of
GlcNAc (39) which is presumably whyManNAc is rotated 180°
when bound to hSP-D (29). This would also be true for pSP-D
which has Lys and Arg in equivalent positions to hSP-D Arg-
343 and Arg-349 (Fig. 6).
The specificity of conglutinin for GlcNAc provided by the
Lys-343 to N-acetyl binding alongside the standard collectin
interactions of theGlcO3 andO4 hydroxyls with calcium and
protein, is enhanced by the extended loop Asn-318–Pro-324,
bounded at both ends by conserved residues which coordinate
both ligand andCa1,which becomes ordered onGlcNAc ligand
binding, with Asp-320 OD1 making a specific interaction
with the N-acetyl nitrogen (Fig. 5). The structure of the
GlcNAc-1-P complex again shows interactionwith Lys-343 in
addition to Ca1 binding-site residues, but with the extended
flexible loop displaced by the phosphate group such that Asp-
320 is no longer within binding distance. The extended flexible
loop in pSP-D (insertion of GSS; Figs. 4 and 6) also becomes
more ordered on sugar binding, although no specific interac-
tions between the loop and bound ligand are reported (40, 41),
whereas the RAK insertion in CL-43 is reported to enhance
specificity for mannose-rich viral glycoconjugates (42).
The combination of a flanking valine (339) with Lys-343 and
Asp-320 appears to be a key element in the recognition and
binding ofGlcNAcby conglutininwith an affinity order ofmag-
nitude higher than other monosaccharides (16–20). The only
Figure 7. Extended binding site interactions. Conglutinin CRD (surface
view) with residues in the extended ligand-binding pocket highlighted in
gray with black labels. Corresponding residues in hSP-D (least squares fit of
1PWB CRD to main chain conglutinin residues 232–319 and 325–351 are
shown in yellowwith orange labels.
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other collectin where GlcNAc is reported to bind with high
affinity (7) is CL-46 which also has a flanking valine, however
the potential GlcNAcN-acetyl coordinating residues, in equiv-
alent positions to conglutinin Lys-343 and Asp-320, are gluta-
mate and asparagine, respectively (Fig. 6). Several other collec-
tins have specificity, albeit usually weak, for GlcNAc ligands
(16, 17), the known structures with bound GlcNAc or GlcNAc
type terminal ligand revealing the orientation of the bound
sugar ring as generally reversed to that observed in the conglu-
tinin structure here. This is the case for two of the three sub-
units in the GlcNAc–rat MBP-A trimeric complex, for
GlcNAc–rat MBP-C (33, 34), and for ManNAc–hSP-D (29).
The exception is the C subunit of rat MBP-A (34) which shows
the same GlcNAc orientation as conglutinin, although this is
thought to be because of crystal contacts and there are no spe-
cific interactions between the protein and the acetyl group.
Although the ability of crystal contacts to influence ligand ori-
entation is well-documented (32), the interaction here of Lys-
246 from a neighboring subunit with GlcNAc O5 and O6 does
not appear to influence ligand orientation, protein-GlcNAc
binding determinants (Glu-315, Asn-317, Glu-325, Asn-337,
Asp-320, Ca1, Lys-343), or the extended loop 318–324, because
each of these for GlcNAc is closely similar to those in both the
unliganded and the ethylene glycol–bound structures where
the Lys-246–ligand interaction is absent. The ligand-binding
site is formed ready to interact with the incoming ligand, the
NZ of the contact residue Lys-246 then shifting by 2 Å to
interact with the bound GlcNAc ligand.
The biological and physiological relevance of the high spec-
ificity for the N-acetyl group, and for GlcNAc in particular, is
far from clear. GlcNAc3Glc represents the conserved motif
hexose-132-hexose in cores of many Enterobacteriaceae,
including all Salmonella, which share a common major core
structure (that of the Ra mutant), and E. coli R2 and K12 (43–
45). Where the LPS is extended to O antigen the Ra GlcNAc is
present as a branch linked through O1 to the LPS main chain
glucose and is thus available for recognition by conglutinin. The
ability of the conglutinin-binding pocket to accommodate the
phosphate in GlcNAc-1-P is an important indicator that
1-linked GlcNAc such as that of the Salmonella LPS can be
recognized and bound by conglutinin. This is consistent with
the in vitro and in vivo studies which demonstrate the antibac-
terial activity of conglutinin against S. typhimurium and E. coli
(8, 9).
Conglutinin, which is known to bind to high mannose-type
oligosaccharide with a preference for the terminal man1–2
sequence (21), binds to the C3-derived glycoprotein iC3b pres-
ent on pathogens and facilitates clearance (13–15), with bind-
ing reported to be exclusively mediated through the N-linked
Man oligosaccharides on the iC3b  chain (23, 46). In addition,
binding to yeast mannan and complement-activated immune
complexes has been shown to be calcium-dependent and inhib-
ited by GlcNAc (12), suggesting a central role for the CRD-
binding site. In our studies, soaking of 1–2-mannobiose into
the unliganded crystals, successfully demonstrated for hSP-D
(32), failed to reveal any ligand in the CRD site (or elsewhere)
even at high concentrations. Because the binding site appears to
be openly accessible in the crystal, the failure to bind this simple
mannobiose suggests a requirement for the iC3b  chain oligo-
saccharide to be presented by the carrier protein iC3b in a con-
formation which enables high-specificity binding (46, 23), per-
haps utilizing an extended binding site as for Salmonella
entericaMinnesota R5 LPS (36). This is supported byMizuochi
et al. (21), who report that highmannose-type oligosaccharides
exhibit increased reactivity from the Man5 to the Man8 struc-
tures. Calcium-dependent binding ofM. bovis Bacille Calmett-
Guérin by conglutinin is also thought to be via terminal diman-
nose units of the bacterial lipoarabinomannan (22), our
inability to visualize binding of simple1–2-mannobiose in the
openly accessible ligand-binding site further suggesting a
requirement for presentation of dimannose as part of extended
physiological ligands. The primary biological roles of bovine
conglutinin remain to be determined as do the details of the
binding interactions with iC3b, bacterial LPS, and viral glycans.
The uniquely designed, highly specific GlcNAc-binding pocket
and the ability of GlcNAc to abolish binding to iC3b suggest a
dual role for conglutinin, directly binding to iC3b via the high
mannose oligosaccharide attached to the N-terminal of the 
chain and directly binding pathogens via exposed and accessi-
ble GlcNAc on the pathogen surface. The competition between
these two conglutinin targets for the Ca1-binding site suggests
overlap between the two recognition sites. Whether congluti-
nin can simultaneously bind, via different homotrimeric CRDs,
to both iC3b coatedmicroorganisms and to themicroorganism
itself is not at all clear, but it would be surprising if the exqui-
sitely designedGlcNAc-binding sitewas not central to the asso-
ciated biological roles.
Experimental procedures
Protein expression
Expression of the recombinant fragment (rf) of bovine con-
glutinin (BC) consisting of the CRD and neck regions (rfBC,
residues 199–351 of native conglutinin) followed the proce-
dure described by Prasad (47) which is based on the initial
cDNA clone of Lu et al. (48) and the transformation into com-
petent E. coli DH5 cells as described by Wang et al. (24).
Briefly, the clone was purified from DH5 and used to trans-
form competent NovaBlue cells for maintaining the plasmid. A
single colony was picked from a LB agar plate (containing 50
g/ml carbenicillin and 34 g/ml chloramphenicol) streaked
withBL21(DE3)pLysS containing the recombinant plasmid and
was used to inoculate 10 ml of LBmedia. The culture was incu-
bated overnight at 37 °C with vigorous shaking (225 rpm). Cells
were harvested next day at 2000 g and washed once in fresh
LB media. The cell pellet was then resuspended into 5 ml of
freshmedia and used as inoculation for 1 liter of fresh LBmedia
containing the antibiotics chloramphenicol (34g/ml) and car-
benicillin (50g/ml) and incubated at 37 °C with vigorous (225
rpm) shaking.
The cells were induced at A600 of 0.6 with isopropyl--D-
thiogalactopyranoside (IPTG, NOVA Biochem), to a final con-
centration of 0.5mM, and incubated further for 2 h. The culture
was then chilled on ice for 30minwith gentle shaking. The cells
were harvested at 8000 g for 10 min at 4 °C and washed once
with fresh media. Samples were analyzed on SDS-PAGE. Sam-
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ples were heated to 100 °C for 5 min (10 min for total cell
lysates). 20l of each sample was loaded onto the wells and run
on a 15% (w/v) acrylamide gel.
Protein extraction
The cell pellet was resuspended in 25 ml of ice-cold cell-lysis
buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM CaCl2)
and frozen at80 °C. The cells were thawed on ice at 4 °C and
the remaining 25 ml of lysis buffer containing Triton X-100
(final concentration 0.05% v/v), DNase (5 g/ml), MgCl2 (0.04
M), and proteases inhibitor mixture tablet was added. The
thawed cell suspensionwas shaken at 4 °C for 45min.The lysate
was then sonicated with 10 30-s pulses of 16 s amplitude at
15-s intervals. After sonication, the cell soup was centrifuged at
15,000  g. The protein, pelleted as inclusion bodies, was
washed twice with ice-cold deionized water to remove traces of
Triton X-100.
The pellet was then subjected to a denaturing and refolding
procedure, involving repetitive dialysis against concentrations
of urea decreasing from 6 M to zero. Before use, all urea solu-
tions were passed through Duolite MB6113 Indicator Mixed
Resin (BDH) to remove traces of cyanate ions, which may irre-
versibly bind to the protein and affect function. The pellet was
resuspended in dialysis buffer (20 mM Tris-HCl, 150 mM NaCl,
5 mM CaCl2, and 5% v/v glycerol) containing 6 M urea and
shaken for 30 min at 4 °C. The denatured protein solution was
centrifuged to remove insoluble material. An activated dialysis
membrane tubing (Medicell 10 K MWCO) was filled with the
cleared supernatant and placed in 2 liters of dialysis buffer con-
taining 4 M urea. The protein was dialyzed against decreasing
concentrations of urea with buffer changes every 2 h followed
by an additional 24-h dialysis to remove traces of urea. The
dialysate was then centrifuged at 15,000 g to remove contam-
inating aggregates. Samples were analyzed on SDS-PAGE for
purity as described elsewhere.
Protein purification and characterization
Protein samples were passed through Anotope 0.2m filters
(Whatman) prior to loading. Purification was performed on a
Pharmacia Biotech AKTA purifier FPLC system.
Ion-exchange purification
20 ml of the dialyzed recombinant protein solution was
diluted to 50 ml with water and loaded at 2 ml/min onto a Fast
Flow Q-Sepharose (16 200 mm) column in 20 mM Tris-HCl
buffer containing 5 mM CaCl2 and 50 mMNaCl. A linear gradi-
ent, 0–50% buffer B (buffer A containing 500 mMNaCl), for 90
minwas used to elute the protein in 2-ml volume fractions. The
fractions were analyzed by SDS-PAGE on 15% (w/v) and the
peak fractions pooled. 10 ml of the sample from the Q-Sephar-
ose, diluted to 50 ml with water to reduce the salt concentra-
tion, was loaded onto a 5  50 mm Mono Q column at 1
ml/min. A steep linear gradient 0–100% buffer B was applied
over 5 min. 1-ml fractions were collected and analyzed by 15%
SDS-PAGE.
Gel-filtration chromatography
The peak fractions from Mono Q were loaded onto a pre-
packed Superdex-75 (HR 10/300 mm) column, 200-l protein
samples were loaded onto the column in Tris buffer, containing
10 mM EDTA. The flow rate was 1 ml/min and 0.5-ml fractions
were collected. The column was calibrated with alcohol dehy-
drogenase (150 kDa), BSA (66 kDa), carbonic anhydrase (29
kDa), and cytochrome C (14.4 kDa).
N-terminal sequencing
The protein samples were run on a 4–12% (w/v) bis-tris
NuPAGE precast gel (Novex UK Ltd) at 200 mA per gel using a
Novex XCell II Mini-cell gel apparatus. The gel was electro-
blotted to ProBlott membrane (PE Applied Biosystems) in a
Bio-Rad Trans-Blot electrophoretic transfer cell. The mem-
brane was stained with Coomassie Brilliant Blue. The rfBC
band was excised and sequenced using Edman degradation on
an Applied Biosystems 494A Procise protein sequencer (PE
Applied Biosystems UK). The samples were run on the
sequencer by applying to a glass fiber disc pretreated with poly-
brene to limit sample washout.
Crystallization and data collection
Crystals of conglutinin were grown in sitting drops consist-
ing of an equal volume (2 l) of protein solution (8 mg ml1
protein in 13 mM Tris, 100 mM NaCl, 7 mM CaCl2, pH 7.5) and
precipitant buffer (2.5 M (NH4)2SO4, 0.1 M Tris, pH 8.0–8.5).
For the initial data, crystals were prepared for cryocooling using
ethylene glycol in precipitant buffer. Successive addition of 2-l
aliquots of increasing concentrations (5, 10, 15, 20%) of ethyl-
ene glycol cryobuffer were added to the well, followed by addi-
tion of a further 2-l aliquot of 20% cryobuffer, and an
exchange of 10 l of the resulting well buffer with 20%
cryobuffer.
Further experiments indicated the crystals lasted longer in
2–4 methanepentanediol and this was then used as the cryo-
protectant for a further unliganded data set and for all the
ligand-bound data, with ligands introduced into crystals by
their inclusion in the cryobuffer. Ligand concentrations in the
cryobuffers for those ligand soaks that showed bound ligand in
electron density maps were 10 mM for GlcNAc and 0.1 M for
GlcNAc-1-P, withCaCl2 added to give a final concentration of
10 mM in the cryobuffers. All ligands were purchased from
Sigma.Where ligand could not be identified in electron density
maps, extended soaking times at higher molarity were followed
by further data collection. All data were collected either at
Daresbury SRS or Diamond Light Source (DLS). Integrated
intensities were calculated with the program MOSFLM (49)
and data processed using CCP4 suite (50). Data collection and
processing statistics are given in Table 1.
Structure solution and refinement
The structure of conglutinin without bound ligand was
solved by molecular replacement with AMoRe (51) using the
homologous hSP-D structure (PDB ID 1PW9) as a search
model. The recombinant homotrimeric fragment of congluti-
nin consisted of the C-terminal 153 residues (Asn-199 to Phe-
351). The size of the unit cell indicated that a trimer would not
fit into the unit cell and there was space only for a monomeric
unit. The neck region of collectin molecules is required for
trimerization (24, 38), suggesting that some or all of the
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expressed neck region (Fig. 2) was absent from the crystallized
protein. This was confirmed by subsequent recharacterization
of the protein used for crystallization byN-terminal sequencing
and SDS-PAGE.
Only the CRD portion (residues hSP-D 236 to 355 which
correspond to conglutinin residues 230 to 351) of the native
recombinant fragment hSP-D structure (PDB ID 1PW9) was
thus used as amolecular replacementmodel.One clear rotation
solution was found in AMoRe and translation functions indi-
cated a space group of P43. Initial electron density maps (50)
indicated the CRD portion only was present in the structure.
Isomorphismwas sufficient to allow the coordinates of the unli-
ganded conglutinin CRD structure to be used as a starting
model for the ligand-bound structures. The ligand-soaked
structures which gave no sign of ligand in the electron density
were not refined further. Cycles of iterative model building and
refinement were performed; early work on the ethylene glycol
and GlcNAc-bound structures used O (52) and CNS (53), how-
ever COOT (54) and REFMAC5 (55) were subsequently used
throughout for refinement of these and all further structures.
Final models were checked via MolProbity (56) and using Pro-
tein Data Bank validation software. For all the structures, the
first few residues at the N terminus are not visible in the elec-
tron density, definition starting at amino acid 230 (Fig. 2). Final
details of the refinement are given in Table 1. There are no
residues in the outlier region of the Ramachandran plot (Mol-
Probity). Figures were generated using CCP4 mg (57).
Coordinates and structure factors have been deposited in the
Protein Data Bank with accession codes 6RYG (unliganded),
6RYJ (ethylene glycol bound), 6RYM (GlcNAc bound), and
6RYN (GlcNAc-1-P bound).
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